Champions Oncology (CSBR) Free Cash Flow (2010 - 2026)
Champions Oncology's (CSBR) quarterly Free Cash Flow came in at -$617000.0 in Q3 2026, down 296.5% year-over-year from $314000.0 in Q3 2025, and up 72.42% on a QoQ basis from -$2.2 million in Q2 2026.
Powered by 
Analysis
Champions Oncology (CSBR) Free Cash Flow (2010 - 2026) Analysis & Trends
Champions Oncology (CSBR) has 17 years of Free Cash Flow data on file, last reported at -$617000.0 in Q3 2026.
- On a quarterly basis, Free Cash Flow fell 296.5% year-over-year to -$617000.0 in Q3 2026; TTM through Jul 2026 was -$6.0 million, a 185.24% decrease from a year earlier, with the FY2026 full-year figure at -$5.0 million, down 171.97% from the prior year.
- Free Cash Flow for Q3 2026 stood at -$617000.0, up from -$2.2 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $6.9 million in Q2 2025 and bottomed at -$4.7 million in Q3 2023.
- Historically, Free Cash Flow has averaged -$20368.4 across 5 years, with a median of -$377000.0 in 2024.
- The widest annual swing landed in 2025, when Free Cash Flow jumped 480.97%; it then slumped 982.05% in 2026.
- Year by year, Free Cash Flow stood at $2.7 million in 2022, then sank by 80.98% to $510000.0 in 2023, then slumped by 173.92% to -$377000.0 in 2024, then sank by 360.74% to -$1.7 million in 2025, then soared by 64.48% to -$617000.0 in 2026.
- Per Business Quant data, the three most recent Free Cash Flow figures were -$617000.0 in Q3 2026, -$2.2 million in Q2 2026, and -$1.4 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 360.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 138.10 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 323.69 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 148.62 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 19.90 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -46.89 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -617,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -2.84 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -3.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -617,000.00 |
| Apr 30, 2026 | -2.24 Mn |
| Jan 31, 2026 | -1.38 Mn |
| Oct 31, 2025 | -1.74 Mn |
| Jul 31, 2025 | 314,000.00 |
| Apr 30, 2025 | 6.91 Mn |
| Jan 31, 2025 | 156,000.00 |
| Oct 31, 2024 | -377,000.00 |
| Jul 31, 2024 | 311,000.00 |
| Apr 30, 2024 | -1.81 Mn |
| Jan 31, 2024 | -1.01 Mn |
| Oct 31, 2023 | 510,000.00 |
| Jul 31, 2023 | -4.66 Mn |
| Apr 30, 2023 | -1.45 Mn |
| Jan 31, 2023 | 819,000.00 |
| Oct 31, 2022 | 2.68 Mn |
| Jul 31, 2022 | -949,000.00 |
| Apr 30, 2022 | 290,000.00 |
| Jan 31, 2022 | 3.85 Mn |
| Oct 31, 2021 | 662,000.00 |